The Discovery Centre (DISC) in Cambridge, UK. (Credit: AstraZeneca)
‘A new era of growth’: AstraZeneca aims for $80B revenue, 20 new drugs by 2030
AstraZeneca on Tuesday morning unveiled its ambitious plan to be one of the fastest growing pharma companies by the end of the decade.
In what …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
